Collectively, these data suggest that HIF2A supports KLF6 expression by acting through the large KLF6 super enhancer, potentially explaining the relatively high KLF6 levels in ccRCC when compared to other tumour types (Supplementary Fig. 1a). The gene discussed is KLF6; the disease is nonpapillary renal cell carcinoma.